These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16415184)
21. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185 [TBL] [Abstract][Full Text] [Related]
22. [Chronic heart failure treatment in the year 2006]. De Berrazueta Fernández JR An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101 [TBL] [Abstract][Full Text] [Related]
25. A basic guide to understanding plasma B-type natriuretic peptide in the diagnosis of congestive heart failure. Kreiger G Medsurg Nurs; 2007 Apr; 16(2):75-8; quiz 79. PubMed ID: 17547263 [TBL] [Abstract][Full Text] [Related]
26. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
27. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related]
28. B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery. Chikovani O; Hsu JH; Keller R; Karl TR; Azakie A; Adatia I; Oishi P; Fineman JR J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1179-87. PubMed ID: 17976447 [TBL] [Abstract][Full Text] [Related]
29. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196 [TBL] [Abstract][Full Text] [Related]
30. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Rodseth RN; Padayachee L; Biccard BM Anaesthesia; 2008 Nov; 63(11):1226-33. PubMed ID: 18673363 [TBL] [Abstract][Full Text] [Related]
31. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients. Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778 [TBL] [Abstract][Full Text] [Related]
32. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. Shih CY; Sapru A; Oishi P; Azakie A; Karl TR; Harmon C; Asija R; Adatia I; Fineman JR J Thorac Cardiovasc Surg; 2006 Mar; 131(3):632-8. PubMed ID: 16515916 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Arya A; Haghjoo M; Dehghani MR; Fazelifar AF; Nikoo MH; Bagherzadeh A; Sadr-Ameli MA Am J Cardiol; 2006 Feb; 97(3):389-92. PubMed ID: 16442402 [TBL] [Abstract][Full Text] [Related]
34. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study. Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187 [TBL] [Abstract][Full Text] [Related]
35. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Felker GM; Hasselblad V; Hernandez AF; O'Connor CM Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866 [TBL] [Abstract][Full Text] [Related]
36. Use of cardiac biomarkers in end-stage renal disease. Wang AY; Lai KN J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158 [TBL] [Abstract][Full Text] [Related]
38. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting. Green SM; Green JA; Januzzi JL Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043 [TBL] [Abstract][Full Text] [Related]
40. The biomarkers are helpful only for the quantification of reality, nothing changes. Clinical decision-making should not be forgotten! Arslan Y Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):473. PubMed ID: 21345834 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]